Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moustapha Hassan

Showing results (11-20 of 147) with videos related to

Pageof 15
Sort By:
Biochemical and Biophysical Research Communications|May 30, 2015
DNA damage, lysosomal degradation and Bcl-xL deamidation in doxycycline- and minocycline-induced cell death in the K562 leukemic cell lineMona Fares, Manuchehr Abedi-Valugerdi, Moustapha Hassan, et al.
Inflammation|March 3, 2017
Switch of Steady-State to an Accelerated Granulopoiesis in Response to Androctonus australis hector VenomAsma Kaddache, Moustapha Hassan, Fatima Laraba-Djebari, et al.
Pediatric Transplantation|July 9, 2011
Therapeutic drug monitoring is essential for intravenous busulfan therapy in pediatric hematopoietic stem cell recipientsReta Malär, Fredrik Sjöö, Katharina Rentsch, et al.
Plos One|November 7, 2015
Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide BioactivationIbrahim El-Serafi, Parvaneh Afsharian, Ali Moshfegh, et al.
International Immunopharmacology|April 16, 2017
Differential effects of low-dose fludarabine or 5-fluorouracil on the tumor growth and myeloid derived immunosuppression status of tumor-bearing miceManuchehr Abedi-Valugerdi, Wenyi Zheng, Fadwa Benkessou, et al.
International Journal of Clinical and Experimental Pathology|September 10, 2011
Dynamics of early histopathological changes in GVHD after busulphan/cyclophosphamide conditioning regimenSulaiman Al-Hashmi, Zuzana Hassan, Behnam Sadeghi, et al.
Clinical Drug Investigation|July 10, 2026
Altered Busulphan Exposure Associated with Concomitant Omeprazole during Hematopoietic Stem Cell Transplantation Conditioning: A Two-Case ReportIbrahim El-Serafi, Rui He, Ying Zhao, et al.
Experimental Hematology|January 18, 2006
A pharmacodynamic study of 5-azacytidine in the P39 cell lineRasheed Khan, Anni Aggerholm, Peter Hokland, et al.
Scandinavian Journal of Gastroenterology|February 6, 2024
Bioengineering vascularized liver tissue for biomedical research and applicationParsa Davoodi, Niloofar Rezaei, Moustapha Hassan, et al.
Pharmacology & Therapeutics|November 11, 2020
Novel molecular targets in gastric adenocarcinomaRoya Ramezankhani, Roya Solhi, Hamidreza Aboulkheyr Es, et al.
Pageof 15

Showing results (11-20 of 147) with videos related to

Sort By:
Pageof 15
Biochemical and Biophysical Research Communications|May 30, 2015
DNA damage, lysosomal degradation and Bcl-xL deamidation in doxycycline- and minocycline-induced cell death in the K562 leukemic cell lineMona Fares, Manuchehr Abedi-Valugerdi, Moustapha Hassan, et al.
Inflammation|March 3, 2017
Switch of Steady-State to an Accelerated Granulopoiesis in Response to Androctonus australis hector VenomAsma Kaddache, Moustapha Hassan, Fatima Laraba-Djebari, et al.
Pediatric Transplantation|July 9, 2011
Therapeutic drug monitoring is essential for intravenous busulfan therapy in pediatric hematopoietic stem cell recipientsReta Malär, Fredrik Sjöö, Katharina Rentsch, et al.
Plos One|November 7, 2015
Cytochrome P450 Oxidoreductase Influences CYP2B6 Activity in Cyclophosphamide BioactivationIbrahim El-Serafi, Parvaneh Afsharian, Ali Moshfegh, et al.
International Immunopharmacology|April 16, 2017
Differential effects of low-dose fludarabine or 5-fluorouracil on the tumor growth and myeloid derived immunosuppression status of tumor-bearing miceManuchehr Abedi-Valugerdi, Wenyi Zheng, Fadwa Benkessou, et al.
International Journal of Clinical and Experimental Pathology|September 10, 2011
Dynamics of early histopathological changes in GVHD after busulphan/cyclophosphamide conditioning regimenSulaiman Al-Hashmi, Zuzana Hassan, Behnam Sadeghi, et al.
Clinical Drug Investigation|July 10, 2026
Altered Busulphan Exposure Associated with Concomitant Omeprazole during Hematopoietic Stem Cell Transplantation Conditioning: A Two-Case ReportIbrahim El-Serafi, Rui He, Ying Zhao, et al.
Experimental Hematology|January 18, 2006
A pharmacodynamic study of 5-azacytidine in the P39 cell lineRasheed Khan, Anni Aggerholm, Peter Hokland, et al.
Scandinavian Journal of Gastroenterology|February 6, 2024
Bioengineering vascularized liver tissue for biomedical research and applicationParsa Davoodi, Niloofar Rezaei, Moustapha Hassan, et al.
Pharmacology & Therapeutics|November 11, 2020
Novel molecular targets in gastric adenocarcinomaRoya Ramezankhani, Roya Solhi, Hamidreza Aboulkheyr Es, et al.
Pageof 15